Pharmacoeconomic analysis of oral therapies for onychomycosis: a US model
Open Access
- 31 August 1996
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 18 (4), 757-777
- https://doi.org/10.1016/s0149-2918(96)80225-6
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Clinical Pearl: Systemic antifungal drugs and drug interactionsJournal of the American Academy of Dermatology, 1995
- Double-blind, parallel-group comparison of terbinafine and griseofulvin in the treatment of toenail onychomycosisJournal of the American Academy of Dermatology, 1995
- Short-duration treatment of fingernail dermatophytosis: A randomized, double-blind study with terbinafine and griseofulvinJournal of the American Academy of Dermatology, 1995
- Mycology of nail disordersJournal of the American Academy of Dermatology, 1994
- New approaches to the treatment of onychomycosisJournal of the American Academy of Dermatology, 1993
- Posttreatment itraconazole levels in the nailJournal of the American Academy of Dermatology, 1992
- Management of onychomycosis with oral terbinafineJournal of the American Academy of Dermatology, 1990
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- A method for the determination of drug effectiveness in onychomycosis: Trials with ketoconazole and griseofulvin ultramicrosizeJournal of the American Academy of Dermatology, 1983
- Ketoconazole in griseofulvin-resistant dermatophytosisJournal of the American Academy of Dermatology, 1982